Jeffery Haines

Title: The Innovative Contributions of Jeffery Haines

Introduction

Jeffery Haines is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of non-human animal models for research purposes. With a total of 2 patents, his work has implications for understanding human diseases and testing potential therapies.

Latest Patents

Haines' latest patents include groundbreaking innovations in the realm of non-human animals comprising a humanized TTR locus. The first patent focuses on non-human animal genomes, non-human animal cells, and methods of using these entities to assess the in vivo efficacy of human-TTR-targeting reagents. This includes the expression of human transthyretin protein or chimeric transthyretin protein in these animals. The second patent details a mouse model that incorporates a humanized TTR locus with a beta-slip mutation, further enhancing the utility of these models in research.

Career Highlights

Jeffery Haines is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to push the boundaries of scientific research. His work is instrumental in developing innovative solutions that can lead to advancements in medical treatments.

Collaborations

Haines collaborates with esteemed colleagues such as Meghan Drummond Samuelson and David Frendewey, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jeffery Haines exemplifies the spirit of innovation in biotechnology through his patents and collaborative efforts. His work not only advances scientific knowledge but also holds promise for future medical breakthroughs.